DNM1L and cancer: Dysregulated expression ratio of Drp1/MFN1-2 proteins, triggered by multiple genetic or epigenetic events [202, 203] has been found to associate with enhanced cell proliferation and metastatic behaviour [204], as well as to poor prognosis in many cancer types [205].